Vanguard Group Inc Capricor Therapeutics, Inc. Transaction History

Vanguard Group Inc

$5.12 Trillion
Q2 2024

A detailed history of Vanguard Group Inc transactions in Capricor Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,548,941 shares of CAPR stock, worth $28.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,548,941

Previous 1,365,903 13.4%

Holding current value

$28.2 Million

Previous $9.27 Million 20.34%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$4.63 - $7.09 $847,465 - $1.3 Million	183,038 Added 13.4%	1,548,941 $7.39 Million
Q1 2024 May 10, 2024	BUY	$3.61 - $6.88 $723,801 - $1.38 Million	200,499 Added 17.2%	1,365,903 $9.27 Million
Q4 2023 Feb 14, 2024	BUY	$2.71 - $5.08 $35,463 - $66,476	13,086 Added 1.14%	1,165,404 $5.7 Million
Q3 2023 Nov 14, 2023	BUY	$3.42 - $7.85 $19,152 - $43,960	5,600 Added 0.49%	1,152,318 $3.94 Million
Q2 2023 Aug 14, 2023	SELL	$3.76 - $5.05 $17,390 - $23,356	-4,625 Reduced 0.4%	1,146,718 $5.48 Million
Q1 2023 May 15, 2023	SELL	$3.78 - $5.03 $81,270 - $108,145	-21,500 Reduced 1.83%	1,151,343 $4.86 Million
Q4 2022 Feb 10, 2023	BUY	$3.36 - $6.55 $1,619 - $3,157	482 Added 0.04%	1,172,843 $4.53 Million
Q3 2022 Nov 14, 2022	BUY	$3.61 - $6.08 $135,375 - $228,000	37,500 Added 3.3%	1,172,361 $7.03 Million
Q2 2022 Aug 12, 2022	BUY	$2.89 - $4.51 $329,064 - $513,522	113,863 Added 11.15%	1,134,861 $3.96 Million
Q1 2022 May 13, 2022	BUY	$2.83 - $5.68 $153,555 - $308,196	54,260 Added 5.61%	1,020,998 $3.5 Million
Q4 2021 Feb 14, 2022	SELL	$2.89 - $4.16 $3,881 - $5,586	-1,343 Reduced 0.14%	966,738 $2.83 Million
Q3 2021 Nov 12, 2021	BUY	$3.8 - $5.23 $170,422 - $234,555	44,848 Added 4.86%	968,081 $3.89 Million
Q2 2021 Aug 13, 2021	BUY	$3.16 - $5.72 $2.92 Million - $5.28 Million	923,233 New	923,233 $4.74 Million

Others Institutions Holding CAPR

# of Institutions

Shares Held

6.3M

Call Options Held

210K

Put Options Held

374K

View Full List

About CAPRICOR THERAPEUTICS, INC.

Ticker CAPR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,346,200
Market Cap $444M
Description
Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...

More about CAPR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Capricor Therapeutics, Inc. Transaction History